Quick Summary
Rojuzda 75mg Injection
Last updated on 31 Mar 2026 | 09:30 AM (IST)
ā¹85219
MRP: ā¹94687.5
(You Save ā¹9468.5)
1 VIAL(s)
Rojuzda 75mg Injection
Salt Composition
LUSPATERCEPTMarketer
BRISTOL MYERS SQUIBB
Prepaid Only. Non-Returnable.
10% OFF
ā¹85219
MRP: ā¹94,687.50
Inclusive of all taxes
10% Off
Salt Composition
LUSPATERCEPTMarketer
BRISTOL MYERS SQUIBB
Prepaid Only. Non-Returnable.
Introduction
Rojuzda 75mg injection contains an active component called luspatercept. This medication is designed to treat certain types of anemia, particularly anemia associated with two rare blood disorders: beta-thalassemia and myelodysplastic syndromes (MDS). Rojuzda 75mg is specifically used to address anemia related to beta-thalassemia, an inherited blood disorder that affects hemoglobin production, and MDS, a group of bone marrow disorders where blood cell production is ineffective. One of the primary benefits of Rojuzda Injection is its ability to reduce the frequency of blood transfusions for patients suffering from these forms of anemia.
When comparing Rojuzda vs Reblozyl, both medications serve similar purposes in treating anemia, but each has its unique dosing and effectiveness profile. The Rojuzda Injection dose may vary depending on the individualās condition and response to the treatment. It's essential to consult with a healthcare provider to determine the most appropriate medication.
Regarding Rojuzda injection cost , itās important to note that the price can vary depending on the region and healthcare system. It's advisable to check with local pharmacies or healthcare providers for the most accurate pricing.
Uses
Rojuzda 75 mg injection uses areĀ
- Beta-thalassemia
- Myelodysplastic syndromes
How Rojuzda 75mg Injection works
Rojuzda 75mg injection is a medication with a therapeutic effect that promotes red blood cell production and reduces the need for blood transfusions in individuals with beta-thalassemia and myelodysplastic syndromes (MDS). By targeting proteins involved in regulating red blood cell formation, this medication stimulates the production of mature red blood cells, leading to increased hemoglobin levels and improved oxygen-carrying capacity. This not only reduces the frequency of blood transfusions but also enhances the quality of life by alleviating fatigue and improving overall well-being. Additionally, it may have disease-modifying effects, potentially mitigating organ complications associated with chronic anemia.
Interaction of Rojuzda 75mg Injection with other drugs
Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Rojuzda 75mg injection, reducing effectiveness by causing undesirable side effects.
Storage conditions
- Stored in the refrigerator at a temperature between 2Ā°C to 8Ā°C (36Ā°F to 46Ā°F).
- Keep away from moisture, heat, and light.
- It should not be frozen.
- Keep away from children and pets.
How to use Rojuzda 75mg Injection
To use Rojuzda 75mg injection, follow the instructions provided by your healthcare provider or as indicated on the medication label. It is typically administered as an injection. The exact dosing and administration instructions may vary based on the specific condition being treated.
Safety Advice for Rojuzda 75mg Injection
Breast Feeding
The safety of Rojuzda 75mg injection during breastfeeding is not well established, and it is recommended to exercise caution and consult a healthcare professional before using this medication while breastfeeding.
Alcohol
It is generally recommended to avoid consuming alcohol while taking Rojuzda 75mg injection. Alcohol can interact with theophylline, one of the components of this medication, and potentially increase the risk of side effects.
Liver
Individuals with pre-existing liver conditions or underlying liver diseases need to consult a healthcare provider before starting treatment.
Lungs
If you have a pre-existing lung condition or any concerns about the impact of Rojuzda 75mg injection on your respiratory health, it is crucial to discuss these concerns with your healthcare provider.
Driving
Rojuzda 75mg injection may cause side effects that can impair driving ability and overall alertness. Common side effects include dizziness, headache, and tremors, affecting coordination and reaction time.
Pregnancy
Rojuzda 75mg injection poses risks to a developing fetus and may cause harm during pregnancy.Ā
Side Effects
RRojuzda side effectsĀ Like all medications, although not everyone will experience them.Ā
Serious:
- Blood clots
- Hypertension (high blood pressure)
- Stroke
- Heart attack
- Venous thromboembolism (blood clot in a vein)
- Thrombosis (blood clotting disorder)
- Embolism (blockage of blood vessels by a clot or other substance)
- Hemorrhage (excessive bleeding)
- Allergic reactions (rare, but may include rash, itching, swelling, severe dizziness, or difficulty breathing)
Common:
- Headache
- Fatigue
- Dizziness
- Nausea
- Joint pain
- Bone pain
- Muscle pain
- Injection site reactions (e.g., pain, redness, swelling)
Expert Tips
-
Regular Monitoring: Monitor blood pressure, liver function, kidney function, and iron levels during treatment.
-
Risk of Clots and Bleeding: Closely monitor for thrombotic events and hemorrhage, especially in individuals with a history of blood clots or clotting disorders.
-
Report Signs of Bleeding: Immediately report any unusual bruising, nosebleeds, or blood in the urine or stool to your healthcare provider.
-
Pregnancy and Breastfeeding Considerations: Discuss the potential risks during pregnancy or breastfeeding with your healthcare provider.
-
Open Communication: Maintain regular communication with your healthcare provider, sharing your medical history, ongoing treatments, and concerns for better management of the treatment.
FAQs about Rojuzda 75mg Injection
Q1.
Can Rojuzda 75mg injection be used in children?
Rojuzda 75mg injection is not approved for children, as its safety and efficacy have not been established in pediatric populations. It is primarily indicated for adult patients with specific medical conditions.
Q2.
Can Rojuzda 75mg injection be used in patients with kidney disease?
Rojuzda 75mg injection may require dose adjustment or close monitoring in patients with kidney disease. Your healthcare provider will assess your kidney function and determine the appropriate dose or any necessary precautions based on your circumstances.
Q3.
Can Rojuzda 75mg injection be used during chemotherapy or radiation therapy?
The use of Rojuzda 75mg injection in conjunction with chemotherapy or radiation therapy has yet to be extensively studied. It is important to discuss your treatment plan with your healthcare provider to determine the most appropriate approach and any potential interactions or effects.
Q4.
Can Rojuzda 75mg injection be used in patients with a history of cardiovascular disease?
Rojuzda 75mg injection should be used cautiously in patients with a history of cardiovascular disease, as it may increase the risk of cardiovascular events such as heart attack or stroke. Your healthcare provider will assess your cardiovascular health and determine the suitability of this medication treatment.
Q5.
Can Rojuzda 75mg injection cause any side effects in patients with a history of bleeding disorders?
Patients with a history of bleeding disorders should be closely monitored during Rojuzda 75mg injection treatment due to the increased risk of hemorrhage. It is important to discuss your medical history with your healthcare provider to determine the appropriate precautions and monitoring plan.
Q6.
Can Rojuzda 75mg injection cause fertility problems?
Rojuzda 75mg injection may affect fertility in both males and females. If you have concerns about fertility or family planning, discussing this with your healthcare provider before starting treatment with Rojuzda 75mg injection is important. They can provide guidance and recommendations based on your circumstances.
Fact Box
|
Molecule name |
Luspatercept |
|
Therapeutic class |
Hematopoietic agent |
|
Pharmacological class |
Erythroid maturation agent |
|
Ā Indications
|
1.Beta-thalassemia 2.Myelodysplastic syndromes |
References
- Lonza Biologics Tuas Pte Ltd, European Medicines Agency, [Revised on 25 June 2020] [Accessed on 17th June 2023], https://www.ema.europa.eu/en/documents/product-information/reblozyl-epar-product-information_en.pdf
- Acceleron Pharma, Inc, US Food and Drug Administration, [Revised on April 2020] [Accessed on 17th June 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761136orig2lbl.pdf
Disclaimer
MrMedās primary intention is to ensure that its consumers get information that experts, accurate and trustworthy, review. The information and contents of this website are for informational purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Please seek your doctor's advice and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Archana Gupta
BDS
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:30 AM (IST)
Want to know more?
Read Our Editorial Policy
